CPC A61K 35/16 (2013.01) [A61K 35/57 (2013.01); A61K 38/1703 (2013.01); A61K 38/1722 (2013.01); A61K 38/1741 (2013.01); A61K 38/1774 (2013.01); A61K 38/40 (2013.01); A61P 25/28 (2018.01)] | 27 Claims |
1. A method of treating a cognitive impairment disorder in a human or companion animal subject, said method comprising:
a. administering to said subject one or more cognitive functioning tests to identify a subject suffering from a cognitive impairment disorder; and
b. orally administering to said subject a therapeutically effective amount of an animal plasma composition;
wherein said administration provides an improvement in said subject's results in said one or more cognitive impairment tests.
|